Alercell is a true innovator, disruptor, and leader in the field of preventative oncology. A young and dynamic company with a team of passionate and dedicated individuals who are committed to making a difference in the fight against cancer and brain diseases pursuing aggressively a more preventative approach to these devastating illnesses.
Alercell growth is fueled by internal research and strategic acquisitions and alliances.
Alercell, Inc. aims to streamline the process for testing of cancer, Leukemia and infectious diseases and developing cancer testing technology with revolutionary in-vitro testability. We imagine a world where testing detects disease at its earliest stage, so preventative measures can be quickly implemented.
Alercell, believes that Dementia and Alzheimer diseases should be treated early and faster to postpone the wellness of patients and their family.
Lena Q51 the most advanced Leukemia diagnostic test